The comparison of remimazolam and midazolam in bronchoscopic sedation: a systematic review and meta-analysis of randomized controlled trials.

Front Med (Lausanne) · 2025 · PMC12279844 · PMID 40697921

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The SMD for recovery time was −0.976, 95% CI (−1.483 to −0.469), and a highly significant p -value of less than 0.001 ( Figure 3B ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.